Trials / Withdrawn
WithdrawnNCT01337570
A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Safety and Efficacy Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- International Partnership for Microbicides, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is a double-blind, randomized, placebo-controlled Phase III study to assess the safety and efficacy of a silicone elastomer vaginal ring containing 25mg of dapivirine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dapivirine | Vaginal ring containing 25mg dapivirine; one ring inserted every 28 days for at least 15 months |
| OTHER | Placebo | Vaginal Ring containing no drug substance |
| DRUG | Dapivirine |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2011-04-19
- Last updated
- 2012-06-11
Locations
5 sites across 4 countries: Malawi, Rwanda, South Africa, Zimbabwe
Source: ClinicalTrials.gov record NCT01337570. Inclusion in this directory is not an endorsement.